Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26(1):1–133. DOI: 10.1089/thy.2016.0628
Mazzaferi E, Mazzaferi E, Saaman N. Thyroid carcinoma: papillary and follicular: Blackwell Scientific; 1993.
Muresan M, Olivier P, Leclère J, et al. Bone metastases from differentiated thyroid carcinoma. Endocr Relat Cancer 2008;15(1):37. DOI: 10.1677/ERC-07-0229
Iñiguez-Ariza NM, Bible KC, Clarke BL. Bone metastases in thyroid cancer. J Bone Oncol 2020;21:100282. DOI: 10.1016/j.jbo.2020.100282
Choksi P, Papaleontiou M, Guo C, et al. Skeletal complications and mortality in thyroid cancer: a population-based study. J Clin Endocrinol Metab 2017;102(4):1254–1260. DOI: 10.1210/jc.2016-3906
Kushchayeva YS, Kushchayev SV, Carroll NM, et al. Spinal metastases due to thyroid carcinoma: an analysis of 202 patients. Thyroid 2014;24(10):1488–1500. DOI: 10.1089/thy.2013.0633
Slook O, Levy S, Slutzky-Shraga I, et al. Long-term outcomes and prognostic factors in patients with differentiated thyroid carcinoma and bone metastases. Endocr Pract 2019;25(5):427–437. DOI: 10.4158/EP-2018-0465
Durante C, Haddy N, Baudin E, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006;91(8):2892–2899. DOI: 10.1210/jc.2005-2838
Yu HHM, Tsai YY, Hoffe SE. Overview of diagnosis and management of metastatic disease to bone. Cancer Control 2012;19(2):84–91. DOI: 10.1177/107327481201900202
Farooki A, Leung V, Tala H, et al. Skeletal-related events due to bone metastases from differentiated thyroid cancer. J Clin Endocrinol Metab 2012;97(7):2433–2439. DOI: 10.1210/jc.2012-1169
Quan GM, Pointillart V, Palussière J, et al. Multidisciplinary treatment and survival of patients with vertebral metastases from thyroid carcinoma. Thyroid 2012;22(2):125–130. DOI: 10.1089/thy.2010.0248
Georgy B. Metastatic spinal lesions: state-of-the-art treatment options and future trends. AJNR Am J Neuroradiol 2008;29(9):1605–1611. DOI: 10.3174/ajnr.A1137
Onimus M, Papin P, Gangloff S. Results of surgical treatment of spinal thoracic and lumbar metastases. European Spine J 1996;5:407–411. DOI: 10.1007/BF00301969
Alvarez L, Perez-Higueras A, Quinones D, et al. Vertebroplasty in the treatment of vertebral tumors: postprocedural outcome and quality of life. European Spine J 2003;12:356–360. DOI: 10.1007/s00586-003-0525-z
Ghanem N, Uhl M, Brink I, et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 2005;55(1):41–55. DOI: 10.1016/j.ejrad.2005.01.016
de Geus-Oei LF, Oei HY, Hennemann G, et al. Sensitivity of 123 I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2002;29:768–774. DOI: 10.1007/s00259-002-0781-x
Freudenberg L, Antoch G, Jentzen W, et al. Value of 124 I-PET/CT in staging of patients with differentiated thyroid cancer. Eur Radiol 2004;14:2092–2098. DOI: 10.1007/s00330-004-2350-0
Bernier MO, Leenhardt L, Hoang C, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001;86(4):1568–1573. DOI: 10.1210/jcem.86.4.7390
Stojadinovic A, Shoup M, Ghossein RA, et al. The role of operations for distantly metastatic well-differentiated thyroid carcinoma. Surgery 2002;131(6):636–643. DOI: 10.1067/msy.2002.124732
Van Geffen E, Wobbes T, Veth RP, et al. Operative management of impending pathological fractures: a critical analysis of therapy. J Surg Oncol 1997;64(3):190–194. DOI: 10.1002/(sici)1096-9098(199703)64:3<190::aid-jso3>3.0.co;2-5
Bickels J, Dadia S, Lidar Z. Surgical management of metastatic bone disease. J Bone Joint Surg Am 2009;91(6):1503–1516. DOI: 10.2106/JBJS.H.00175
Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366(9486):643–648. DOI: 10.1016/S0140-6736(05)66954-1
Boussios S, Cooke D, Hayward C, et al. Metastatic spinal cord compression: unraveling the diagnostic and therapeutic challenges. Anticancer Res 2018;38(9):4987–4997. DOI: 10.21873/anticanres.12817
Van Tol K, Hew J, Jager P, et al. Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 2000;52(5):653–659. DOI: 10.1046/j.1365-2265.2000.00998.x
Eustatia-Rutten C, Romijn J, Guijt M, et al. Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab 2003;88(7):3184–3189. DOI: 10.1210/jc.2003-030231
Lüftner D, Henschke P, Possinger K. Clinical value of bisphosphonates in cancer therapy. Anticancer Res 2007;27(4A):1759–1768. PMID: 17649770.
Zheng G, Chang B, Lin F, et al. Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours. Eur J Cancer Care (Engl) 2017;26(6):e12541. DOI: 10.1111/ecc.12541
